Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer

Firas Abdollah, Maxine Sun, Rodolphe Thuret, Claudio Jeldres, Zhe Tian, Alberto Briganti, Shahrokh F. Shariat, Paul Perrotte, Francesco Montorsi, Pierre I. Karakiewicz

Research output: Contribution to journalArticlepeer-review


Objectives: To test the relationship between the extent of pelvic lymph node dissection at radical prostatectomy and the rate of lymph node metastases, and to identify the ideal number of lymph nodes that should be removed to achieve an optimal staging. Methods: We assessed 20789 prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection between 2004 and 2006. Receiver operating characteristics analyses were used to define the probability of correctly staging lymph node metastases patients according to lymph node count. Univariable and multivariable regression analyses tested the relationship between lymph node count and lymph node metastases rate. Results: The average lymph node count was 6.4 (median 5.0). Overall, the lymph node metastases rate was 2.5%; and it resulted to be 0.2, 1.5 and 6.7% in low, intermediate and high-risk tumors, respectively. The rate of lymph node metastases was 3.5 and 6.7% in patients with 10 and 20 lymph node count, respectively. Removing 20 lymph nodes yielded a 90% probability of correctly staging lymph node metastases, regardless of risk group. In multivariable analysis, lymph node count was an independent predictor of lymph node metastases stage (odds ratio: 1.07, P

Original languageEnglish
Pages (from-to)645-651
Number of pages7
JournalInternational Journal of Urology
Issue number7
Publication statusPublished - Jul 2012


  • Lymph node excision/standards
  • Male
  • Pelvis
  • Prostatectomy
  • Prostatic neoplasms/surgery

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer'. Together they form a unique fingerprint.

Cite this